Download PDF
Semin intervent Radiol 2023; 40(03): 258-261
DOI: 10.1055/s-0043-1769774
Review Article

Diaphragmatic Injury with Empyema Development after Microwave Ablation of a Liver Dome Lesion

Ran Jing
1   Integrated IR/DR Residency, Michigan Medicine, Ann Arbor, Michigan
,
Travis Merritt
1   Integrated IR/DR Residency, Michigan Medicine, Ann Arbor, Michigan
,
Joseph J. Gemmete
2   Departments of Radiology, Neurosurgery, Neurology, and Otolaryngology, Michigan Medicine, Ann Arbor, Michigan
› Author Affiliations
› Further Information
Also available at
    Permissions and Reprints

Abstract

Percutaneous microwave ablation (MWA) of the liver is a minimally invasive procedure that utilizes high frequency electromagnetic waves to generate heat and induce tumor necrosis. MWA has been proven to be a safe and effective treatment option for primary and metastatic liver tumors. The treatment of liver dome lesions can present a technical challenge due to the proximity of the hepatic dome to the diaphragm and lung parenchyma. In this report, we present a case of diaphragmatic injury and subsequent empyema following MWA of a liver dome lesion.

Keywords

microwave ablation - liver - complication - antibiotics


Publication History

Article published online:
20 July 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Izzo F, Granata V, Grassi R. et al. Radiofrequency ablation and microwave ablation in liver tumors: an update. Oncologist 2019; 24 (10) e990-e1005
    CrossrefPubMedGoogle Scholar
  • 2 Fang C, Cortis K, Yusuf GT. et al. Complications from percutaneous microwave ablation of liver tumours: a pictorial review. Br J Radiol 2019; 92 (1099): 20180864
    CrossrefPubMedGoogle Scholar
  • 3 Knavel EM, Brace CL. Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol 2013; 16 (04) 192-200
    CrossrefPubMedGoogle Scholar
  • 4 Liang P, Wang Y, Yu X, Dong B. Malignant liver tumors: treatment with percutaneous microwave ablation – complications among cohort of 1136 patients. Radiology 2009; 251 (03) 933-940
    CrossrefPubMedGoogle Scholar
  • 5 Bertot LC, Sato M, Tateishi R, Yoshida H, Koike K. Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review. Eur Radiol 2011; 21 (12) 2584-2596
    CrossrefPubMedGoogle Scholar
  • 6 Kambadakone A, Baliyan V, Kordbacheh H. et al. Imaging guided percutaneous interventions in hepatic dome lesions: tips and tricks. World J Hepatol 2017; 9 (19) 840-849
    CrossrefPubMedGoogle Scholar
  • 7 Tsoumakidou G, Buy X, Garnon J, Enescu J, Gangi A. Percutaneous thermal ablation: how to protect the surrounding organs. Tech Vasc Interv Radiol 2011; 14 (03) 170-176
    CrossrefPubMedGoogle Scholar
  • 8 Knuttinen MG, Van Ha TG, Reilly C, Montag A, Straus C. Unintended thermal injuries from radiofrequency ablation: organ protection with an angioplasty balloon catheter in an animal model. J Clin Imaging Sci 2014; 4: 1
    CrossrefPubMedGoogle Scholar
  • 9 Hermida M, Cassinotto C, Piron L. et al. Percutaneous thermal ablation of hepatocellular carcinomas located in the hepatic dome using artificial carbon dioxide pneumothorax: retrospective evaluation of safety and efficacy. Int J Hyperthermia 2018; 35 (01) 90-96
    CrossrefPubMedGoogle Scholar
  • 10 Song SY, Chung JW, Han JK. et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 2001; 12 (03) 313-320
    CrossrefPubMedGoogle Scholar
  • 11 Patel S, Tuite CM, Mondschein JI, Soulen MC. Effectiveness of an aggressive antibiotic regimen for chemoembolization in patients with previous biliary intervention. J Vasc Interv Radiol 2006; 17 (12) 1931-1934
    CrossrefPubMedGoogle Scholar
  • 12 Geschwind JF, Kaushik S, Ramsey DE, Choti MA, Fishman EK, Kobeiter H. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors. J Vasc Interv Radiol 2002; 13 (11) 1163-1166
    CrossrefPubMedGoogle Scholar
  • 13 Khan W, Sullivan KL, McCann JW. et al. Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study. AJR Am J Roentgenol 2011; 197 (02) W343-W345
    CrossrefPubMedGoogle Scholar